SCHEMBL5846360

SCHEMBL5846360

COC(=O)c1ccc(-c2ccc(-c3ccccc3)c(-c3ccc4c(c3)C(C)(C)CCC4(C)C)c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
RARB P10826 13/20 0.65
RARG P13631 13/20 0.65
RXRA P19793 3/20 0.65
RARA P10276 11/20 0.60
EGFR P00533 1/20 0.58
CYP3A4 P08684 3/20 0.51
PTGS2 P35354 1/20 0.50
CYP26A1 O43174 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5846339 0.91 RARG (0.62) RARBRARGRXRARARAEGFR
SCHEMBL5845788 0.89 RARG (0.60) RARBRARGRXRARARAEGFR
SCHEMBL5846429 0.88 RARB (0.83) RARBRARGRXRARARA
SCHEMBL7873016 0.88 RARB (0.83) RARBRARGRXRARARA
SCHEMBL5846624 0.88 RARB (0.83) RARBRARGRXRARARA
SCHEMBL5846390 0.88 RARG (0.58) RARBRARGRXRARARAEGFR
SCHEMBL5847632 0.86 RARB (0.67) RARBRARGRXRARARA
SCHEMBL5846789 0.86 RARG (0.67) RARBRARGRXRARARA
SCHEMBL5846968 0.86 RARG (0.55) RARBRARGRXRARARAEGFR
SCHEMBL5846034 0.86 RARB (0.82) RARBRARGRXRARARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040030141-A1 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them GALDERMA RESEARCH & DEVELOPMENT 2004-02-12 US claimed
EP-0952974-B1 BIPHENYL DERIVATIVES SUBSTITUTED BY AN AROMATIC OR HETEROAROMATIC RADICAL AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME GALDERMA RES & DEV (FR) 2001-11-21 EP claimed
US-7148245-B2 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them GALDERMA RESEARCH & DEVELOPMENT (FR) 2006-12-12 US disclosed
US-20040030141-A1 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them GALDERMA RESEARCH & DEVELOPMENT 2004-02-12 US disclosed
US-6649612-B1 Combating skin ageing and keratinization GALDERMA RESEARCH & DEVELOPMENT (FR) 2003-11-18 US disclosed
US-6316009-B1 FOR THERAPY OF DERMATOLOGICAL COMPLAINTS ASSOCIATED WITH A KERATINIZATION DISORDER, AND FOR COMBATING AGEING OF THE SKIN GALDERMA RESEARCH & DEVELOPMENT (FR) 2001-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040030141-A1 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them AHR, TYR, CYP1A1 RARB 26/4885RARG 39/4885RXRA 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.